Trial of Azithromycin in Severe COVID-19 Patients Finds No Benefit Trial of Azithromycin in Severe COVID-19 Patients Finds No Benefit

A clinical trial of the widely-used antibiotic azithromycin in COVID-19 patients in hospital has found no convincing evidence of benefit, prompting doctors to announce on Monday that they have closed that section of the trial.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news